Has anyone been able to find the scientific paper this was published in or is purely hype from the company?
I am a little sceptical as it is hard to get antibodies to cross the blood-brain barrier and even harder to get them inside the cell. Of course there is the other issue that it is all pre-clinical.
Ann: PAT-DX1 Crosses Blood Brain Barrier to Reduce Tumour Size, page-68
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $11.11K | 1.587M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1230203 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 3783696 | 5 |
View Market Depth
| Last trade - 15.43pm 09/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |